Only show
results from:

Sort results by:

Display preferences
1,006 results sorted by relevancy Results per page:
AEterna Zentaris Enters a License and Collaboration Agreement with Spectrum Pharmaceuticals on Fourth Generation LHRH Antagonist D-63153 after Zentaris Regains Worldwide Rights to D-63153 from Baxter Healthcare.
PR Newswire; Aug 12, 2004; 700+ Words ...PRNewswire/ -- - All amounts are in Canadian dollars AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) announced today...s website at www.spectrumpharm.com . About AEterna Zentaris Inc. AEterna Zentaris Inc. is a biopharmaceutical company...
AEterna Zentaris Announces Initiation of a European Multi-Center Phase II Trial of D-63153 in Benign Prostate Hyperplasia.
PR Newswire; Apr 13, 2005; 700+ Words ...PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS...Spectrum Pharmaceuticals, Inc. , AEterna Zentaris' U.S. development partner...potential sales in Japan. About AEterna Zentaris Inc. AEterna Zentaris Inc. is...
Atrium Announces Bought Deal-Secondary Offering by AEterna Zentaris - AEterna Zentaris intends to complete the spin-off of Atrium by the end of 2006 - Multiple voting share structure to be eliminated
CCNMatthews Newswire; Sep 19, 2006; 700+ Words ...Atrium" or "the Company"), (TSX:ATB) announces that Atrium and its principal shareholder AEterna Zentaris Inc. ("AEterna Zentaris"), (TSX:AEZ)(NASDAQ:AEZS) have entered into an agreement with RBC Capital Markets for the...
AEterna Zentaris Announces Details of Distribution of its Remaining Shares of Atrium Biotechnologies Inc.
PR Newswire; Oct 25, 2006; 700+ Words ...QUEBEC CITY, Oct. 25 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS), a growing global...voting shares of Atrium Biotechnologies held by AEterna Zentaris by way of reduction of the stated capital of AEterna...
AEterna Zentaris In. Review in Progress.
M2 Presswire; Apr 11, 2008; 700+ Words ...2008, we have added AEterna Zentaris In. (NASDAQ: AEZS) to the...numerous publicly traded companies AEterna Zentaris Inc. was down less than $0.50...Friday, April 11, 2008- AEterna Zentaris Inc., a global biopharmaceutical...
AEterna Zentaris appoints a Board Vice Chairman, a New Chair of the Corporate Governance Committee, Two New Scientific Advisory Board Members and an IR Director.
PR Newswire; Nov 21, 2005; 700+ Words ...QUEBEC CITY, Nov. 21 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) today announced...Vice Chairman of the Board. Mr. Ernst had joined AEterna Zentaris' Board last February. In addition, Pierre MacDonald...
AEterna Zentaris to Sell 3,485,000 Subordinate Voting Shares of Atrium Biotechnologies Through Secondary Offering - AEterna Zentaris to become a pure play biopharmaceutical company focused on endocrine therapy and oncology - AEterna Zentaris intends to complete...
CCNMatthews Newswire; Sep 19, 2006; 700+ Words ...in the United States. AEterna Zentaris Inc. (TSX:AEZ)(NASDAQ...Atrium Biotechnologies Inc. (Atrium), representing 24% of AEterna Zentaris' ownership interest...Atrium Biotechnologies Inc. (TSX:ATB) is a...
AEterna Zentaris Shareholders Approve Reduction in Stated Capital and Distribution of Remaining Shares of Atrium Biotechnologies Inc.
PR Newswire; Dec 15, 2006; 700+ Words ...Canada, Dec. 15 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS), a growing global...buy any securities in any jurisdiction. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a growing global biopharmaceutical...
AEterna Zentaris Gets $52.5M from Cetrotide Royalty Sale.(AEterna Zentaris Inc.)(Cowen Healthcare Royalty Partners LP )
BIOWORLD Today; Nov 13, 2008; ; 700+ Words ...during the past year, AEterna Zentaris Inc. continued its asset...Frontier Scientific Inc. for about $3.2 million. Engel said AEterna Zentaris has plenty of additional...Biopharmaceuticals Inc., and AEterna Zentaris also is conducting...
AEterna Zentaris' Partner Spectrum Granted IND from FDA to Conduct Phase I/II Clinical Trial with D-63153 in Hormone-Dependent Prostate Cancer in the United States.
PR Newswire; May 31, 2005; 700+ Words ...QUEBEC CITY, May 31 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS) announced that...prostate cancer in the course of his lifetime. About AEterna Zentaris Inc. AEterna Zentaris Inc. is an oncology and endocrine therapy...
AEterna Zentaris Receives First Regulatory Approval for Impavido(R) for Parasitic Skin Disease.
PR Newswire Europe; Mar 30, 2005; 700+ Words ...FRANKFURT, Germany, March 30 /PRNewswire/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS) announced it has...its annual sales were US$159 million. About AEterna Zentaris Inc. AEterna Zentaris Inc. is an oncology and endocrine therapy...
AEterna Zentaris Enters Into a License and Collaboration Agreement With Tulane University for a Novel Class of Potential Anti-Cancer Agents - Growth Hormone Releasing Hormone Antagonists.
PR Newswire Europe; Oct 27, 2004; 700+ Words ...QUEBEC, Canada, October 27 /PRNewswire/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS) today announced...production of IGF-I and IGF-II in tumors. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a biopharmaceutical company...
AEterna Zentaris Completes Distribution of Remaining Shares of Atrium Biotechnologies.
PR Newswire; Jan 3, 2007; 700+ Words ...CITY, Jan. 3 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS), a growing global...buy any securities in any jurisdiction. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a growing global biopharmaceutical...
AEterna Zentaris Strengthens its Position in the Development of Innovative Signal Transduction Inhibitors as a Potential Way to Treat Cancer.
PR Newswire; Jan 6, 2005; 700+ Words ...inhibitor candidate, Erucylphosphocholine (ErPC) AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) today announced...Lake City, the Company has 30 employees. About AEterna Zentaris Inc. AEterna Zentaris Inc. is an oncology and endocrine therapy...
/C O R R E C T I O N from Source -- AEterna Zentaris Inc./.
PR Newswire; Oct 25, 2006; 700+ Words ...Notice. Corrected copy follows: AEterna Zentaris Announces Details of Distribution...Shares of Atrium Biotechnologies Inc. QUEBEC CITY, Oct. 25 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS...
AEterna Zentaris to Present at Three Upcoming Conferences: ASCO, BIO 2004 and Needham Biotechnology Conference.
PR Newswire; Jun 3, 2004; 700+ Words ...QUEBEC CITY, Quebec, June 3 /PRNewswire/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) announced today...period of 90 days at the same address. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a biopharmaceutical company...
AEterna Zentaris Subsidiary Atrium Biotechnologies Completes Initial Public and Secondary Offering Totalling $75 Million; All Amounts are in Canadian Dollars.
PR Newswire; Apr 6, 2005; 700+ Words ...Canada, April 6 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) today announced...from U.S. registration requirements. About AEterna Zentaris Inc. AEterna Zentaris Inc. is an oncology and endocrine therapy...
AEterna Zentaris Announces Decision to Continue Cetrorelix Development in Benign Prostate Hyperplasia in Japan.
PR Newswire; Mar 16, 2005; 700+ Words ...CITY, March 16 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS) today announced...represents a market of US$1.7 billion. About AEterna Zentaris Inc. AEterna Zentaris Inc. is an oncology and endocrine therapy...
AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency.
PR Newswire; Oct 19, 2009; 700+ Words ...CITY, Oct. 19 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company...waiving User fees at the time a NDA is filed. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a global biopharmaceutical company...
AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results.(Financial report)
CNW Group; Nov 13, 2008; 700+ Words ...COMTEX) -- All amounts are in U.S. dollars AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical...Juergen Engel, Ph.D. as President and CEO of AEterna Zentaris, replacing Juergen Ernst who had been acting as...
1,006 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives